Cardiovascular medicine has evolved over the last few decades, with the advent of
percutaneous interventional treatments. In particular, balloon angioplasty and …

Coronary stent implantation is the second great advance in the treatment of obstructive
coronary artery disease since the introduction of balloon catheter angioplasty. However, in …

Background Coatings consisting of a polymer and drug are widely used in drug‐eluting
stents (DES) and are essential in providing programmable drug release kinetics. Among …

Percutaneous coronary intervention with drug-eluting stents (DES) is a well-established and
widelyaccepted treatment approach in patients with coronary artery disease. Although the …

The efficacy and safety of drug-eluting coronary stents might differ depending on the
pharmacologic agents and stent delivery systems used. Recent research has focused on the …

Coronary stenting has revolutionized current perspective of coronary artery disease
management. Bare-metal stents (BMS) were introduced in 1994, but long-term results have …

Nanotechnology is poised to have an increasing impact on cardiovascular health in coming
years. Diagnostically, multiplexed point‐of‐care devices will enable rapid genotyping and …

Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an
estimated 17.9 million lives each year, representing one third of global mortality. As existing …

The introduction of intracoronary stents represented a major advance in interventional
cardiology. While bare metal stents set the benchmark for improved safety over angioplasty …

Drug-eluting stents (DESs) have revolutionized interventional cardiology over the past few
years to the extent that balloon angioplasty and bare stents did in the 1980s and 1990s. The …